Beacon Pointe Advisors, LLC / LLY
Beacon Pointe Advisors, LLC’s Eli Lilly & Co Position
Does Beacon Pointe Advisors, LLC own Eli Lilly & Co (LLY)? Yes — 62.1K shares worth $57M (+0.30% of its 13F portfolio) as of Q1 2026, up from 45.1K shares the prior filed quarter.
Position Value
$57M
Q1 2026
Shares
62.1K
% of Portfolio
+0.30%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 62.1K | $57M | +0.30% |
| Q4 2025 | 45.1K | $48M | +0.34% |
| Q3 2025 | 43.8K | $33M | +0.28% |
| Q2 2025 | 45.2K | $35M | +0.37% |
| Q1 2025 | 79.4K | $66M | +0.74% |
| Q4 2024 | 69.9K | $54M | +0.60% |
| Q3 2024 | 57.6K | $51M | +0.59% |
| Q2 2024 | 50.3K | $46M | +0.54% |
| Q1 2024 | 44.2K | $34M | +0.38% |
| Q4 2023 | 66.1K | $39M | +0.46% |
| Q3 2023 | 66.0K | $35M | +0.44% |
| Q2 2023 | 53.8K | $25M | +0.41% |
| Q1 2023 | 70.9K | $24M | +0.41% |
| Q4 2022 | 40.2K | $15M | +0.29% |
| Q3 2022 | 29.7K | $10M | +0.22% |
| Q2 2022 | 29.8K | $10M | +0.20% |
| Q1 2022 | 28.9K | $8M | +0.11% |
| Q4 2021 | 19.6K | $5M | +0.14% |
| Q3 2021 | 20.5K | $5M | +0.12% |
| Q2 2021 | 12.4K | $3M | +0.10% |
| Q1 2021 | 7.6K | $1M | +0.09% |
| Q4 2020 | 8.1K | $1M | +0.09% |
| Q3 2020 | 6.7K | $991,000 | +0.10% |
| Q2 2020 | 7.3K | $1M | +0.12% |
| Q1 2020 | 6.2K | $861,000 | +0.14% |
| Q4 2019 | 4.4K | $578,000 | +0.18% |
| Q3 2019 | 4.6K | $517,000 | +0.22% |
| Q2 2019 | 5.0K | $553,000 | +0.20% |
| Q1 2019 | 4.9K | $638,000 | +0.24% |
| Q4 2018 | 5.2K | $600,000 | +0.36% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Beacon Pointe Advisors, LLC’s full portfolio or all institutional holders of LLY.